Lorbriqua 100Mg Strip Of 10 Tablets (Pack Of 3)
10 Tablet(s) in StripMRP ₹312000.00
₹280400.00
10% OFF
Made by
PFIZER PRODUCT INDIA PRIVATE LIMITED
Dosage
TABLET
Expiry
Product Summary
| Uses | Anti- cancer |
| Therapy | Anti-neoplastic |
| Side effects | Weight gain, joint pain, high cholesterol |
| Salt Content | Lorlatinib(100.0 Mg) |
Assurance
available
Regulated
Medical Description
Lorbriqua tablet is a prescription oral targeted anticancer medication that belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs). It is primarily used for the treatment of Adult Patients With Metastatic Non-Small Cell Lung Cancer (Nsclc) Whose Tumors Are Anaplastic Lymphoma Kinase (Alk) Positive. The medication works by blocking specific enzymes that promote cancer cell growth and survival, helping slow disease progression.
This medicine comes as film-coated oral tablets for once-daily dosing. Swallow the tablets whole with a glass of water, without crushing, splitting, or chewing, to ensure the correct amount of medication is absorbed. Your oncologist will determine the exact dose, which may be adjusted during your treatment based on how well you tolerate the medicine.
Treatment with Lorbriqua tablet requires careful medical supervision by an experienced oncologist. Because this medication can affect the nervous system, lipid levels, liver function , and heart rhythm, regular clinical monitoring is mandatory. Frequent blood tests and clinical check-ups are essential to detect and manage potential side effects promptly.
Patients receiving this therapy should be fully informed about potential risks, including mood or speech changes, cognitive changes , high cholesterol and triglycerides , and heart-related effects . Close communication with your healthcare team is vital to ensure that any symptoms are addressed early and your treatment remains safe and effective.
Uses
Contraindications
- If you have a known hypersensitivity or severe allergic reaction to lorlatinib or any of the inactive ingredients in the tablet formulation.
- With strong CYP3A inducers, such as rifampicin, as they can significantly reduce lorlatinib levels and may reduce its effectiveness.
- During pregnancy unless specifically considered necessary by your doctor.
- Breastfeeding should be avoided during treatment and for the recommended period after the final dose.
Side effects
- High cholesterol and triglyceride levels
- Edema (swelling, particularly in the hands, ankles, or feet)
- Peripheral neuropathy (numbness, tingling, or pain in the hands and feet)
- Cognitive effects (such as memory loss, confusion, or difficulty speaking)
- Fatigue and weakness
- Weight gain and joint pain
- Diarrhea and nausea
- Mood changes (including anxiety, depression, or irritability)
- High blood pressure
- Headache and dizziness
- Skin rash
- Severe cognitive or psychiatric effects (such as severe depression, hallucinations, or suicidal thoughts)
- Heart rhythm abnormalities, including atrioventricular block and PR-interval prolongation
- Pancreatitis (severe abdominal pain)
- Interstitial lung disease (severe breathing difficulties or cough)
- Significant liver enzyme elevations
Precautions and Warnings
Pregnancy
Breast Feeding
Alcohol
Driving
Other General Warnings
- You notice new or worsening mood changes, personality shifts, or difficulty speaking/thinking.
- You experience signs of a heart rhythm problem, such as fainting, dizziness, or an abnormal heartbeat.
- You develop a new or worsening cough or shortness of breath.
- You have a history of liver disease or heart rhythm problems.
- You develop significant swelling, weight gain, or high blood pressure.
- Your cholesterol or triglyceride levels become elevated.
Directions for Use
- Take Lorbriqua tablet orally exactly as prescribed by your doctor, once daily at the same time each day.
- Swallow the tablets whole with a glass of water; do not crush, split, or chew them.
- You may take this medication either with or without food.
- Continue your treatment until disease progression or unacceptable toxicity, as determined by your doctor.
Storage and disposal
- Store the tablets at room temperature, according to the product's storage instructions.
- Keep the medication container tightly closed and out of the reach of children and pets.
- Return any unused or expired tablets to your pharmacist for safe disposal.
Quick Tips
- Keep all scheduled blood test appointments to monitor your cholesterol, triglycerides, liver function, blood pressure, and general health.
- Report any changes in your speech, memory, mood, or ability to focus to your doctor immediately.
- Your doctor may prescribe treatment to control increased cholesterol or triglyceride levels.
- Tell your healthcare providers you are taking this medication before any surgery or dental work.
- Contact your doctor right away if you develop a new or worsening cough or shortness of breath.
- Use effective contraception as advised by your doctor.
Dosage
Overdose
- If you think you have taken more Lorbriqua tablet than prescribed, contact your doctor or seek emergency medical attention immediately.
- Treatment of overdose is supportive, as there is no specific antidote.
Missed a Dose
- If you miss a dose of Lorbriqua tablet, take it as soon as you remember, unless it is close to your next scheduled dose.
- Never take a double dose to make up for a missed dose.
How does this medicine work?
Interactions
Interactions with other medicines
- Avoid strong CYP3A inducers (such as rifampicin, carbamazepine, or St. John's wort), as they can significantly reduce blood levels and effectiveness of the medication.
- Strong CYP3A inhibitors (such as ketoconazole, clarithromycin, or ritonavir) can increase lorlatinib levels. If a strong CYP3A inhibitor cannot be avoided, your doctor may need to adjust the dose and monitor you closely.
- Inform your doctor about all prescription drugs, over-the-counter medicines, and herbal supplements you are taking, especially those that may affect your heart rhythm or liver.
Interactions with food items
- Lorbriqua tablet may be taken with or without food.
- Avoid grapefruit and grapefruit juice, as they may increase lorlatinib levels.
- Maintain a balanced diet and stay adequately hydrated throughout treatment.
Frequently Asked Questions (FAQs)
References:
- Central Drugs Standard Control Organisation (CDSCO). Drugs@CDSCO [Internet]. New Delhi: Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India; [cited 2026 Aug 19].
- electronic medicines compendium (emc). Lorviqua 25 mg film-coated tablets - Summary of Product Characteristics (SmPC) [Internet]. Sandwich: Pfizer Limited; 2023 Dec [cited 2026 Aug 19].
- European Commission. Community Register of medicinal products for human use: Lorviqua (lorlatinib) [Internet]. Brussels: European Commission; 2020 [cited 2026 Aug 19].
- Pfizer Inc. Lorbrena (lorlatinib) tablets prescribing information [Internet]. New York: Pfizer Inc; 2022 [cited 2026 Aug 19].
- Macmillan Cancer Support. Lorlatinib [Internet]. London: Macmillan Cancer Support; 2024 [cited 2026 Aug 19].
Articles
View AllChronic Condition Articles
View AllDid you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:LORBRIQUA
Manufacturer Name:PFIZER PRODUCT INDIA PRIVATE LIMITED
Address:Pfizer manufacturing deutschland gmbh, betriebsstatte freiburg, mooswaldallee1, 79090 freiburg,germany.
Country of Origin:Germany
Vendor Details
Fulfillment Information: Lorbriqua 100 MG Tablet (10) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.





















